Anjuli May Jaen

Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Changgui Li, Shoujie Huang, Xiangzhong Ye, 2023, The Lancet. Respiratory medicine.

Immunogenicity and safety of boosting with a recombinant two-component SARS-CoV-2 vaccine: two randomized, parallel-controlled, phase 2 studies.

Jing-xin Li, A. Alamadi, Aala Hassan, 2024, Expert review of vaccines.